Global Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030

Description

List of Tables

The global Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 8.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Global Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar, Egypt, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the global Fluorescent in Situ Hybridization (FISH) market are:

Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine

Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases

Market Players

Some of the major market players operating in the global Fluorescent in Situ Hybridization (FISH) market are:

Abbott

Abcam plc.

Abnova Corporation

Agilent Technologies, Inc.

Bio SB

Biocare Medical, LLC

BioCat GmbH

BioDot

BioGenex

Bio-Techne

BIOZOL Diagnostics Vertrieb GmbH

Excilone

F.Hoffmann-La Roche Ltd

Genemed Biotechnologies, Inc.

Kaneka Eurogentec S.A.

Leica Biosystems Nussloch GmbH

Merck KGaA

MetaSystems

Sysmex Asia-Pacific Pte Ltd (a subsidiary of Sysmex Corporation)

Thermo Fischer Scientific Inc.

Zytomed Systems GmbH

1 INTRODUCTION 68

1.1 OBJECTIVES OF THE STUDY 68
1.2 MARKET DEFINITION 68
1.3 OVERVIEW 68
1.4 CURRENCY AND PRICING 70
1.5 LIMITATIONS 70
1.6 MARKETS COVERED 71

2 MARKET SEGMENTATION 74

2.1 MARKETS COVERED 74
2.2 GEOGRAPHICAL SCOPE 75
2.3 YEARS CONSIDERED FOR THE STUDY 76
2.4 DBMR TRIPOD DATA VALIDATION MODEL 77
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 80
2.6 MULTIVARIATE MODELLING 81
2.7 MARKET APPLICATION COVERAGE GRID 82
2.8 PRODUCT LIFELINE CURVE 83
2.9 DBMR MARKET POSITION GRID 84
2.10 VENDOR SHARE ANALYSIS 86
2.11 SECONDARY SOURCES 87
2.12 ASSUMPTIONS 87

3 EXECUTIVE SUMMARY 88

4 PREMIUM INSIGHTS 91

4.1 PORTER'S FIVE FORCES 94
4.2 PESTEL ANALYSIS 95
4.3 INDUSTRY INSIGHTS 96
4.4 CONCLUSION 97

5 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: REGULATORY FRAMEWORK 98

6 MARKET OVERVIEW 100

6.1 DRIVERS 102
- 6.1.1 GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER 102
- 6.1.2 INNOVATION AND ADVANCEMENTS IN FISH PRODUCTS 102
- 6.1.3 HIGH FUNDING FOR RESEARCH ACTIVITIES 103
- 6.1.4 RISING DEMAND AND USAGE OF FISH TECHNIQUES 103
6.2 RESTRAINTS 104
- 6.2.1 HIGH COST OF FISH TESTING 104
- 6.2.2 LIMITED AVAILABILITY OF SKILLED PROFESSIONALS 104
6.3 OPPORTUNITIES 105
- 6.3.1 RISING PUBLIC AWARENESS ABOUT THE EARLY DETECTION OF GENETIC ABNORMALITIES 105
- 6.3.2 RISE IN DEVELOPMENT OF SPECIFIC BIOMARKERS AND VARIOUS PROBES 105
6.4 CHALLENGES 106
- 6.4.1 STRINGENT GOVERNMENT REGULATIONS FOR THE APPROVAL OF FISH PROBES 106
- 6.4.2 ETHICAL CONCERNS ASSOCIATED WITH FISH TECHNOLOGY 106

7 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE 107

7.1 OVERVIEW 108
7.2 CONSUMABLES 111
- 7.2.1 FISH PROBE 111
  - 7.2.1.1 FISH PROBE, BY PROBE TYPE 112
    - 7.2.1.1.1 CHROMOSOME FISH PROBE 112
    - 7.2.1.1.2 SPLIT FISH PROBES 112
    - 7.2.1.1.3 TRANSLOCATION FISH PROBES 112
    - 7.2.1.1.4 SUBTELOMERE FISH PROBES 112
    - 7.2.1.1.5 PRENATAL FISH PROBES 112
    - 7.2.1.1.6 OTHERS PROBES 113
  - 7.2.1.2 FISH PROBE, BY TECHNOLOGY 113
    - 7.2.1.2.1 FLOW FLUORESCENT IN SITU HYBRIDIZATION 113
    - 7.2.1.2.2 C-ISH 113
    - 7.2.1.2.3 D-ISH 113
    - 7.2.1.2.4 Q- FLUORESCENT IN SITU HYBRIDIZATION 113
    - 7.2.1.2.5 OTHERS 113
  - 7.2.1.3 FISH PROBE, BY TYPE 114
    - 7.2.1.3.1 RNA 114
    - 7.2.1.3.1.1 MRNA 114
    - 7.2.1.3.1.2 MIRNA 114
    - 7.2.1.3.1.3 OTHERS 115
    - 7.2.1.3.2 DNA 115
- 7.2.2 ACCESSORY KITS & REAGENTS 115
  - 7.2.2.1 KITS 115
  - 7.2.2.2 BUFFER 115
  - 7.2.2.3 DYES 115
  - 7.2.2.4 OTHERS 116
7.3 INSTRUMENT 116
- 7.3.1 STANDALONE 117
- 7.3.2 PORTABLE 117
- 7.3.3 HANDHELD 117
7.4 SOFTWARE 117

8 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY 118

8.1 OVERVIEW 119
8.2 RNA FLUORESCENT IN SITU HYBRIDIZATION 122
8.3 DNA FLUORESCENT IN SITU HYBRIDIZATION 123
8.4 PNA FLUORESCENT IN SITU HYBRIDIZATION 124
8.5 OTHERS 125

9 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION 126

9.1 OVERVIEW 127
9.2 CANCER RESEARCH 130
- 9.2.1 CANCER RESEARCH, BY CANCER TYPE 131
  - 9.2.1.1 NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) 131
    - 9.2.1.1.1 BREAST CANCER 131
    - 9.2.1.1.2 LUNG CANCER 131
    - 9.2.1.1.3 MELANOMA 132
    - 9.2.1.1.4 PROSTRATE CANCER 132
    - 9.2.1.1.5 OVARIAN CANCER 132
    - 9.2.1.1.6 OTHERS 132
  - 9.2.1.2 HEMATOPOETIC MALIGNANCIES 132
    - 9.2.1.2.1 LEUKEMIA 132
    - 9.2.1.2.2 MULTIPLE MYELOMA 133
    - 9.2.1.2.3 MYELODYSPLASTIC SYNDROMES (MDS) 133
- 9.2.2 CANCER RESEARCH, BY PRODUCT 133
  - 9.2.2.1 CONSUMABLES 133
  - 9.2.2.2 INSTRUMENTS 133
  - 9.2.2.3 SOFTWARE 133
9.3 GENETIC RESEARCH 134
- 9.3.1 CYTOGENETICS 135
- 9.3.2 CHROMOSOMAL ABNORMALITIES 135
- 9.3.3 OTHERS 135
9.4 INFECTIOUS DISEASE 135
- 9.4.1 CONSUMABLES 136
- 9.4.2 INSTRUMENTS 136
- 9.4.3 SOFTWARE 136
9.5 PERSONALIZED MEDICINE 136
9.6 OTHERS 137

10 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE 138

10.1 OVERVIEW 139
10.2 RESEARCH 142
- 10.2.1 INSTRUMENTS 142
- 10.2.2 CONSUMABLES 143
- 10.2.3 SOFTWARE 143
10.3 CLINICAL 143
- 10.3.1 CONSUMABLES 144
- 10.3.2 INSTRUMENT 144
- 10.3.3 SOFTWARE 144
10.4 COMPANION DIAGNOSTIC 144
- 10.4.1 CONSUMABLES 145
- 10.4.2 INSTRUMENT 145
- 10.4.3 SOFTWARE 145

11 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER 146

11.1 OVERVIEW 147
11.2 DIAGNOSTIC LABORATORIES 150
11.3 HOSPITALS & CLINICS 150
11.4 PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES 151
11.5 ACADEMIC & RESEARCH INSTITUTES 152
11.6 CONTRACT RESEARCH ORGANIZATIONS 152
11.7 OTHERS 153

12 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL 154

12.1 OVERVIEW 155
12.2 RETAIL SALES 158
12.3 ONLINE SALES 158
12.4 DIRECT TENDER 159
12.5 OTHERS 160

13 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION 161

13.1 OVERVIEW 162
13.2 NORTH AMERICA 167
- 13.2.1 U.S. 180
- 13.2.2 CANADA 188
- 13.2.3 MEXICO 196
13.3 EUROPE 204
- 13.3.1 GERMANY 218
- 13.3.2 U.K. 226
- 13.3.3 ITALY 234
- 13.3.4 FRANCE 242
- 13.3.5 SPAIN 250
- 13.3.6 RUSSIA 258
- 13.3.7 SWITZERLAND 266
- 13.3.8 TURKEY 274
- 13.3.9 BELGIUM 282
- 13.3.10 NETHERLANDS 290
- 13.3.11 DENMARK 298
- 13.3.12 SWEDEN 306
- 13.3.13 POLAND 314
- 13.3.14 NORWAY 322
- 13.3.15 FINLAND 330
- 13.3.16 REST OF EUROPE 338
13.4 ASIA-PACIFIC 339
- 13.4.1 JAPAN 353
- 13.4.2 CHINA 361
- 13.4.3 SOUTH KOREA 369
- 13.4.4 INDIA 377
- 13.4.5 SINGAPORE 385
- 13.4.6 THAILAND 393
- 13.4.7 INDONESIA 402
- 13.4.8 MALAYSIA 410
- 13.4.9 PHILIPPINES 418
- 13.4.10 AUSTRALIA 426
- 13.4.11 NEW ZEALAND 434
- 13.4.12 VIETNAM 442
- 13.4.13 TAIWAN 450
- 13.4.14 REST OF ASIA-PACIFIC 458
13.5 SOUTH AMERICA 459
- 13.5.1 BRAZIL 471
- 13.5.2 ARGENTINA 479
- 13.5.3 REST OF SOUTH AMERICA 487
13.6 MIDDLE EAST AND AFRICA 488
- 13.6.1 SOUTH AFRICA 502
- 13.6.2 SAUDI ARABIA 512
- 13.6.3 EGYPT 520
- 13.6.4 UAE 529
- 13.6.5 KUWAIT 537
- 13.6.6 QATAR 546
- 13.6.7 OMAN 554
- 13.6.8 BAHRAIN 563
- 13.6.9 REST OF MIDDLE EAST AND AFRICA 571

14 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, COMPANY LANDSCAPE 572

14.1 COMPANY SHARE ANALYSIS: GLOBAL 572
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 573
14.3 COMPANY SHARE ANALYSIS: EUROPE 574
14.4 COMPANY SHARE ANALYSIS: EUROPE 575

15 SWOT ANALYSIS 576

16 COMPANY PROFILE 577

16.1 MERCK KGAA 577
- 16.1.1 COMPANY SNAPSHOT 577
- 16.1.2 REVENUE ANALYSIS 577
- 16.1.3 COMPANY SHARE ANALYSIS 578
- 16.1.4 PRODUCT PORTFOLIO 578
- 16.1.5 RECENT DEVELOPMENT 578
16.2 ABBOTT 579
- 16.2.1 COMPANY SNAPSHOT 579
- 16.2.2 REVENUE ANALYSIS 579
- 16.2.3 COMPANY SHARE ANALYSIS 580
- 16.2.4 PRODUCT PORTFOLIO 580
- 16.2.5 RECENT DEVELOPMENT 581
16.3 AGILENT TECHNOLOGIES, INC. 582
- 16.3.1 COMPANY SNAPSHOT 582
- 16.3.2 REVENUE ANALYSIS 582
- 16.3.3 COMPANY SHARE ANALYSIS 583
- 16.3.4 PRODUCT PORTFOLIO 583
- 16.3.5 RECENT DEVELOPMENT 583
16.4 F. HOFFMANN-LA ROCHE LTD. 584
- 16.4.1 COMPANY SNAPSHOT 584
- 16.4.2 REVENUE ANALYSIS 584
- 16.4.3 COMPANY SHARE ANALYSIS 585
- 16.4.4 PRODUCT PORTFOLIO 585
- 16.4.5 RECENT DEVELOPMENT 585
16.5 THERMO FISCHER SCIENTIFIC INC. 586
- 16.5.1 COMPANY SNAPSHOT 586
- 16.5.2 REVENUE ANALYSIS 586
- 16.5.3 COMPANY SHARE ANALYSIS 587
- 16.5.4 PRODUCT PORTFOLIO 587
- 16.5.5 RECENT DEVELOPMENT 588
16.6 ABCAM PLC. 589
- 16.6.1 COMPANY SNAPSHOT 589
- 16.6.2 REVENUE ANALYSIS 589
- 16.6.3 COMPANY SHARE ANALYSIS 590
- 16.6.4 PRODUCT PORTFOLIO 590
- 16.6.5 RECENT DEVELOPMENTS 590
16.7 ABNOVA CORPORATION 592
- 16.7.1 COMPANY SNAPSHOT 592
- 16.7.2 PRODUCT PORTFOLIO 592
- 16.7.3 RECENT DEVELOPMENT 592
16.8 BIO SB 593
- 16.8.1 COMPANY SNAPSHOT 593
- 16.8.2 PRODUCT PORTFOLIO 593
- 16.8.3 RECENT DEVELOPMENT 593
16.9 BIOCARE MEDICAL, LLC 594
- 16.9.1 COMPANY SNAPSHOT 594
- 16.9.2 PRODUCT PORTFOLIO 594
- 16.9.3 RECENT DEVELOPMENT 595
16.10 BIOCAT GMBH 596
- 16.10.1 COMPANY SNAPSHOT 596
- 16.10.2 PRODUCT PORTFOLIO 596
- 16.10.3 RECENT DEVELOPMENT 597
16.11 BIODOT 598
- 16.11.1 COMPANY SNAPSHOT 598
- 16.11.2 PRODUCT PORTFOLIO 598
- 16.11.3 RECENT DEVELOPMENT 598

16.12 BIOGENEX 599
- 16.12.1 COMPANY SNAPSHOT 599
- 16.12.2 PRODUCT PORTFOLIO 599
- 16.12.3 RECENT DEVELOPMENT 599
16.13 BIO-TECHNE 600
- 16.13.1 COMPANY SNAPSHOT 600
- 16.13.2 REVENUE ANALYSIS 600
- 16.13.3 COMPANY SHARE ANALYSIS 601
- 16.13.4 PRODUCT PORTFOLIO 601
- 16.13.5 RECENT DEVELOPMENT 601
16.14 BIOZOL DIAGNOSTICS VERTRIEB GMBH 602
- 16.14.1 COMPANY SNAPSHOT 602
- 16.14.2 PRODUCT PORTFOLIO 602
- 16.14.3 RECENT DEVELOPMENT 603
16.15 EXCILONE 604
- 16.15.1 COMPANY SNAPSHOT 604
- 16.15.2 PRODUCT PORTFOLIO 604
- 16.15.3 RECENT DEVELOPMENT 604
16.16 GENEMED BIOTECHNOLOGIES, INC. 605
- 16.16.1 COMPANY SNAPSHOT 605
- 16.16.2 PRODUCT PORTFOLIO 605
- 16.16.3 RECENT DEVELOPMENT 605
16.17 KANEKA EUROGENTEC S.A. 606
- 16.17.1 COMPANY SNAPSHOT 606
- 16.17.2 PRODUCT PORTFOLIO 606
- 16.17.3 RECENT DEVELOPMENT 606
16.18 LEICA BIOSYSTEMS NUSSLOCH GMBH 607
- 16.18.1 COMPANY SNAPSHOT 607
- 16.18.2 PRODUCT PORTFOLIO 607
- 16.18.3 RECENT DEVELOPMENT 607
16.19 METASYSTEMS 608
- 16.19.1 COMPANY SNAPSHOT 608
- 16.19.2 PRODUCT PORTFOLIO 608
- 16.19.3 RECENT DEVELOPMENT 608
16.20 SYSMEX ASIA PACIFIC PTE LTD (A SUBSIDIARY OF SYSMEX CORPORATION) 609
- 16.20.1 COMPANY SNAPSHOT 609
- 16.20.2 REVENUE ANALYSIS 609
- 16.20.3 PRODUCT PORTFOLIO 610
- 16.20.4 RECENT DEVELOPMENT 610
16.21 ZYTOMED SYSTEMS GMBH 611
- 16.21.1 COMPANY SNAPSHOT 611
- 16.21.2 PRODUCT PORTFOLIO 611
- 16.21.3 RECENT DEVELOPMENT 611

17 QUESTIONNAIRE 612

18 RELATED REPORTS 616

LIST OF TABLES

TABLE 1 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 2 GLOBAL CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 3 GLOBAL CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 4 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 112
TABLE 5 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 113
TABLE 6 GLOBAL FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 114
TABLE 7 GLOBAL RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 8 GLOBAL ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 9 GLOBAL INSTRUMENT IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 10 GLOBAL INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 11 GLOBAL SOFTWARE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 117
TABLE 12 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 121
TABLE 13 GLOBAL RNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 122
TABLE 14 GLOBAL DNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 123
TABLE 15 GLOBAL PNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 124
TABLE 16 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 125
TABLE 17 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 18 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 19 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
TABLE 20 GLOBAL NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 21 GLOBAL HEMATOPOETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 22 GLOBAL CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 23 GLOBAL GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 134
TABLE 24 GLOBAL GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
TABLE 25 GLOBAL INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 135
TABLE 26 GLOBAL INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 27 GLOBAL PERSONALIZED MEDICINE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 137
TABLE 28 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 137
TABLE 29 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 141
TABLE 30 GLOBAL RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 142
TABLE 31 GLOBAL RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 142
TABLE 32 GLOBAL CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 143
TABLE 33 GLOBAL CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 144
TABLE 34 GLOBAL COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 145
TABLE 35 GLOBAL COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 145
TABLE 36 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 149
TABLE 37 GLOBAL DIAGNOSTIC LABORATORIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 150
TABLE 38 GLOBAL HOSPITALS & CLINICS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 151
TABLE 39 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 151
TABLE 40 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 152
TABLE 41 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 153
TABLE 42 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 153
TABLE 43 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 157
TABLE 44 GLOBAL RETAIL SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 158
TABLE 45 GLOBAL ONLINE SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 159
TABLE 46 GLOBAL DIRECT TENDER IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 159
TABLE 47 GLOBAL OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 160
TABLE 48 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 166
TABLE 49 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 171
TABLE 50 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
TABLE 51 NORTH AMERICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
TABLE 52 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 172
TABLE 53 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 172
TABLE 54 NORTH AMERICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
TABLE 55 NORTH AMERICA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 56 NORTH AMERICA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
TABLE 57 NORTH AMERICA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
TABLE 58 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 174
TABLE 59 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 175
TABLE 60 NORTH AMERICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 175
TABLE 61 NORTH AMERICA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
TABLE 62 NORTH AMERICA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 176
TABLE 63 NORTH AMERICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
TABLE 64 NORTH AMERICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 65 NORTH AMERICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 66 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
TABLE 67 NORTH AMERICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
TABLE 68 NORTH AMERICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 178
TABLE 69 NORTH AMERICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 179
TABLE 70 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 179
TABLE 71 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 179
TABLE 72 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 73 U.S. CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
TABLE 74 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 181
TABLE 75 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 181
TABLE 76 U.S. FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
TABLE 77 U.S. RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
TABLE 78 U.S. ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
TABLE 79 U.S. INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 183
TABLE 80 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 183
TABLE 81 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 183
TABLE 82 U.S. CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 184
TABLE 83 U.S. NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 84 U.S. HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
TABLE 85 U.S. CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 185
TABLE 86 U.S. GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 185
TABLE 87 U.S. INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 185
TABLE 88 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
TABLE 89 U.S. RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
TABLE 90 U.S. CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 186
TABLE 91 U.S. COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 187
TABLE 92 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 187
TABLE 93 U.S. FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 187
TABLE 94 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
TABLE 95 CANADA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
TABLE 96 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 189
TABLE 97 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 189
TABLE 98 CANADA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 190
TABLE 99 CANADA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 100 CANADA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 190
TABLE 101 CANADA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
TABLE 102 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 191
TABLE 103 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 191
TABLE 104 CANADA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 192
TABLE 105 CANADA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
TABLE 106 CANADA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
TABLE 107 CANADA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 193
TABLE 108 CANADA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 193
TABLE 109 CANADA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 193
TABLE 110 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
TABLE 111 CANADA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
TABLE 112 CANADA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 194
TABLE 113 CANADA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 195
TABLE 114 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 195
TABLE 115 CANADA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 195
TABLE 116 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
TABLE 117 MEXICO CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
TABLE 118 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 197
TABLE 119 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 197
TABLE 120 MEXICO FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 198
TABLE 121 MEXICO RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
TABLE 122 MEXICO ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 198
TABLE 123 MEXICO INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
TABLE 124 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 199
TABLE 125 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 199
TABLE 126 MEXICO CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 200
TABLE 127 MEXICO NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 200
TABLE 128 MEXICO HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 200
TABLE 129 MEXICO CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 201
TABLE 130 MEXICO GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 201
TABLE 131 MEXICO INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 201
TABLE 132 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
TABLE 133 MEXICO RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
TABLE 134 MEXICO CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 202
TABLE 135 MEXICO COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 203
TABLE 136 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 203
TABLE 137 MEXICO FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 203
TABLE 138 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 209
TABLE 139 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210
TABLE 140 EUROPE CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210

LIST OF FIGURES

FIGURE 1 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 74
FIGURE 2 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DATA TRIANGULATION 77
FIGURE 3 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DROC ANALYSIS 78
FIGURE 4 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 79
FIGURE 5 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY RESEARCH ANALYSIS 79
FIGURE 6 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: INTERVIEW DEMOGRAPHICS 80
FIGURE 7 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: MARKET APPLICATION COVERAGE GRID 82
FIGURE 8 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DBMR MARKET POSITION GRID 84
FIGURE 9 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: VENDOR SHARE ANALYSIS 86
FIGURE 10 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 90
FIGURE 11 THE GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER AND HIGH FUNDING FOR RESEARCH ACTIVITIES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET FROM 2023 TO 2030 91
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET IN 2023 AND 2030 91
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030 92
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030 93
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET 101
FIGURE 16 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2022 108
FIGURE 17 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 109
FIGURE 18 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 109
FIGURE 19 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 110
FIGURE 20 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2022 119
FIGURE 21 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 120
FIGURE 22 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, CAGR (2023-2030) 120
FIGURE 23 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, LIFELINE CURVE 121
FIGURE 24 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2022 127
FIGURE 25 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 128
FIGURE 26 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, CAGR (2023-2030) 128
FIGURE 27 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, LIFELINE CURVE 129
FIGURE 28 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2022 139
FIGURE 29 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2023-2030 (USD MILLION) 140
FIGURE 30 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, CAGR (2023-2030) 140
FIGURE 31 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, LIFELINE CURVE 141
FIGURE 32 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2022 147
FIGURE 33 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2023-2030 (USD MILLION) 148
FIGURE 34 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, CAGR (2023-2030) 148
FIGURE 35 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, LIFELINE CURVE 149
FIGURE 36 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2022 155
FIGURE 37 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 156
FIGURE 38 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 156
FIGURE 39 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 157
FIGURE 40 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 163
FIGURE 41 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2022) 164
FIGURE 42 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2023 & 2030) 164
FIGURE 43 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY REGION (2022 & 2030) 165
FIGURE 44 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE (2023 & 2030) 165
FIGURE 45 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 168
FIGURE 46 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 169
FIGURE 47 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 169
FIGURE 48 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 170
FIGURE 49 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 170
FIGURE 50 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 205
FIGURE 51 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 206
FIGURE 52 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 206
FIGURE 53 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 207
FIGURE 54 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 208
FIGURE 55 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 340
FIGURE 56 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 341
FIGURE 57 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 341
FIGURE 58 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 342
FIGURE 59 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 343
FIGURE 60 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 460
FIGURE 61 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 461
FIGURE 62 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 461
FIGURE 63 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 462
FIGURE 64 SOUTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 462
FIGURE 65 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 489
FIGURE 66 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 490
FIGURE 67 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 490
FIGURE 68 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 491
FIGURE 69 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 492
FIGURE 70 GLOBAL FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 572
FIGURE 71 NORTH AMERICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 573
FIGURE 72 EUROPE FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 574
FIGURE 73 ASIA-PACIFIC FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 575